表紙
市場調查報告書

心律管理設備:醫療設備的開發平台評估

Cardiac Rhythm Management Devices - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 350911
出版日期 內容資訊 英文 338 Pages
訂單完成後即時交付
價格
心律管理設備:醫療設備的開發平台評估 Cardiac Rhythm Management Devices - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月24日內容資訊: 英文 338 Pages
簡介

本報告提供全球心律管理 (CRM) 設備市場上主要的開發中產品 (醫療設備)與其臨床實驗的進展調查,再彙整產品特性比較分析 (臨床實驗的各進展階段) ,以及主要企業簡介及代表性產品,近來的市場動靜 (資本交易·產業聯盟等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 心律管理設備市場概要

第3章 心律管理設備市場:臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各市場區隔
  • 開發中產品:各地區
  • 開發中產品:法規途徑別
  • 開發中產品:估計認證時期別
  • 開發中產品:現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 心律管理設備的企業:各臨床實驗階段的開發中產品
  • 心律管理設備:各臨床實驗階段的開發中產品

第5章 心律管理設備市場:企業·產品概要

  • AI Medical Semiconductor Ltd.
    • 開發中產品及進行中的臨床實驗概要
  • AIS Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Boston TransTec, LLC
  • CardiaLen, Inc.
  • CVRx, Inc.
  • DHS Medical
  • Duke University
  • EBR Systems, Inc.
  • Endurance Rhythm Inc.
  • Greatbatch, Inc.
  • Hadasit Medical Research Services & Development Ltd
  • Impulse Dynamics N.V.
  • Imricor Medical Systems, Inc.
  • InnerPulse, Inc.
  • Kenergy Inc.
  • Krisara Engineering, LLC
  • LifeWave Hi-Tech Medical Devices Ltd.
  • Mathematical Bio-Solutions Inc.
  • Mayo Clinic
  • Medtronic plc
  • MicroPort Scientific Corporation
  • MRI Interventions, Inc
  • NanoLinea
  • NDSU Research Foundation
  • NuVascular Technologies Inc
  • Odem Medical Ltd.
  • Perpetuum Ltd.
  • Queen Mary University of London
  • Rochester Institute of Technology
  • Semprus BioSciences
  • Smartwave Medical Ltd
  • Sorin Group Italia S.r.l
  • Sorin S.p.A. (Inactive)
  • St. Jude Medical, Inc.
  • The Johns Hopkins University
  • The University of Utah
  • TransWorld Med Corporation
  • U.S. Stem Cell, Inc.
  • University of Bern
  • University of California, Los Angeles
  • University of Leicester
  • University of Michigan

第6章 心律管理設備市場:目前的趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0895EPD

GlobalData's Medical Devices sector report, "Cardiac Rhythm Management Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Cardiac Rhythm Management Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Rhythm Management Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Rhythm Management Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Rhythm Management Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Rhythm Management Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 9
  • 1.2 List of Figures 15

2 Introduction 17

  • 2.1 Cardiac Rhythm Management Devices Overview 17

3 Products under Development 19

  • 3.1 Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development 19
  • 3.2 Cardiac Rhythm Management Devices - Pipeline Products by Segment 20
  • 3.3 Cardiac Rhythm Management Devices - Pipeline Products by Territory 21
  • 3.4 Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path 22
  • 3.5 Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date 23
  • 3.6 Cardiac Rhythm Management Devices - Ongoing Clinical Trials 24

4 Cardiac Rhythm Management Devices - Pipeline Products under Development by Companies 25

  • 4.1 Cardiac Rhythm Management Devices Companies - Pipeline Products by Stage of Development 25
  • 4.2 Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development 28

5 Cardiac Rhythm Management Devices Companies and Product Overview 31

  • 5.1 A3 Remote Monitoring Technologies Pvt. Ltd. Company Overview 31
    • 5.1.1 A3 Remote Monitoring Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.2 AIS Inc. Company Overview 32
    • 5.2.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.3 Angel Medical Systems Inc Company Overview 33
    • 5.3.1 Angel Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.4 Arizona State University Company Overview 34
    • 5.4.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.5 AtaCor Medical Inc Company Overview 35
    • 5.5.1 AtaCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.6 Biotronik SE & Co KG Company Overview 38
    • 5.6.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.7 Boston Scientific Corp Company Overview 43
    • 5.7.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.8 Boston TransTec LLC Company Overview 60
    • 5.8.1 Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.9 CardiaLen, Inc. Company Overview 61
    • 5.9.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.10 Cardioalarm, Inc Company Overview 64
    • 5.10.1 Cardioalarm, Inc Pipeline Products & Ongoing Clinical Trials Overview 64
  • 5.11 Children's National Health System Company Overview 65
    • 5.11.1 Children's National Health System Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.12 Columbia University Company Overview 66
    • 5.12.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.13 Corhythm Inc Company Overview 67
    • 5.13.1 Corhythm Inc Pipeline Products & Ongoing Clinical Trials Overview 67
  • 5.14 Coridea, LLC Company Overview 68
    • 5.14.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.15 CVRx Inc Company Overview 69
    • 5.15.1 CVRx Inc Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.16 DHS Medical Company Overview 74
    • 5.16.1 DHS Medical Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.17 Drexel University Company Overview 76
    • 5.17.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.18 Duke University Company Overview 77
    • 5.18.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 77
  • 5.19 EBR Systems Inc Company Overview 78
    • 5.19.1 EBR Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 78
  • 5.20 Endurance Rhythm Inc. Company Overview 82
    • 5.20.1 Endurance Rhythm Inc. Pipeline Products & Ongoing Clinical Trials Overview 82

6 Cardiac Rhythm Management Devices- Recent Developments 173

  • 6.1 Nov 22, 2019: Stereotaxis CEO to present at the 12th Annual BIOMEDevice San Jose Conference 173
  • 6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 173
  • 6.3 Nov 18, 2019: Integer updates 2019 guidance following customer chapter 11 filing, no change in prior view of 2020 sales outlook 175
  • 6.4 Nov 14, 2019: Stereotaxis reports 2019 third quarter financial results 176
  • 6.5 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 177

7 Appendix 335

  • 7.1 Methodology 335
  • 7.2 About GlobalData 338
  • 7.3 Contact Us 338
  • 7.4 Disclaimer 338

List of Tables

  • Table 1: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development 19
  • Table 2: Cardiac Rhythm Management Devices - Pipeline Products by Segment 20
  • Table 3: Cardiac Rhythm Management Devices - Pipeline Products by Territory 21
  • Table 4: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path 22
  • Table 5: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date 23
  • Table 6: Cardiac Rhythm Management Devices - Ongoing Clinical Trials 24
  • Table 7: Cardiac Rhythm Management Devices Companies - Pipeline Products by Stage of Development 25
  • Table 8: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development 28
  • Table 9: A3 Remote Monitoring Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 10: Wireless Device - Wearable Cardiac Rhythm Management System - Product Status 31
  • Table 11: Wireless Device - Wearable Cardiac Rhythm Management System - Product Description 31
  • Table 12: AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 13: Guardian - Product Status 32
  • Table 14: Guardian - Product Description 32
  • Table 15: Angel Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 16: Acute Ischemia Monitor - Product Status 33
  • Table 17: Acute Ischemia Monitor - Product Description 33
  • Table 18: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 19: Wireless Pacemaker System - Product Status 34
  • Table 20: Wireless Pacemaker System - Product Description 34
  • Table 21: AtaCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 22: AtaCor Pacing System - Product Status 35
  • Table 23: AtaCor Pacing System - Product Description 35
  • Table 24: AtaCor Medical Inc - Ongoing Clinical Trials Overview 36
  • Table 25: AtaCor Pacing System - Subcostal Temporary Extracardiac Pacing Study: Clinical Study of the AtaCor Extracardiac Pacing System 37
  • Table 26: Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 27: BioMonitor III - Product Status 38
  • Table 28: BioMonitor III - Product Description 39
  • Table 29: Biotronik SE & Co KG - Ongoing Clinical Trials Overview 40
  • Table 30: BioMonitor III - Bio|Concept.Biomonitor III 41
  • Table 31: BioMonitor III - BIO|MASTER.BIOMONITOR III 41
  • Table 32: BioMonitor III - BIO|STREAM.ICM: Observation of Clinical Routine Care for Patients with BIOTRONIK Implantable Cardiac Monitors (ICMs) 41
  • Table 33: BioMonitor III - Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation (HYBRID AF) 42
  • Table 34: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 35: EMBLEM MRI S-ICD System - Aged Patients - Product Status 44
  • Table 36: EMBLEM MRI S-ICD System - Aged Patients - Product Description 44
  • Table 37: EMPOWER Leadless Pacer - Product Status 44
  • Table 38: EMPOWER Leadless Pacer - Product Description 45
  • Table 39: INGENIO 2 PG - MICS - Product Status 45
  • Table 40: INGENIO 2 PG - MICS - Product Description 45
  • Table 41: Loop Recorder - Product Status 46
  • Table 42: Loop Recorder - Product Description 46
  • Table 43: LUX - Dx Insertable Cardiac Monitor - Product Status 46
  • Table 44: LUX - Dx Insertable Cardiac Monitor - Product Description 47
  • Table 45: MRI-Safe Implantable Cardiac Rhythm Management Lead - Product Status 47
  • Table 46: MRI-Safe Implantable Cardiac Rhythm Management Lead - Product Description 47
  • Table 47: Next Gen CRM PG - Product Status 48
  • Table 48: Next Gen CRM PG - Product Description 48
  • Table 49: Next Generation ICD Lead - Product Status 48
  • Table 50: Next Generation ICD Lead - Product Description 49
  • Table 51: Next Generation ICD/CRT-D - Product Status 49
  • Table 52: Next Generation ICD/CRT-D - Product Description 49
  • Table 53: Next Generation Quad Polar CRT-D - Product Status 50
  • Table 54: Next Generation Quad Polar CRT-D - Product Description 50
  • Table 55: NG3 Non Quad System - Product Status 50
  • Table 56: NG3 Non Quad System - Product Description 51
  • Table 57: Resonate 2.0 - Product Status 51
  • Table 58: Resonate 2.0 - Product Description 51
  • Table 59: S-ICD System 1.5 - Product Status 52
  • Table 60: S-ICD System 1.5 - Product Description 52
  • Table 61: S-ICD System 2.0 - Product Status 52
  • Table 62: S-ICD System 2.0 - Product Description 53
  • Table 63: Temporary RV VVI pacing - Product Status 53
  • Table 64: Temporary RV VVI pacing - Product Description 53
  • Table 65: VITALITY NXT Defibrillator - Product Status 54
  • Table 66: VITALITY NXT Defibrillator - Product Description 54
  • Table 67: X4 SYSTEM + QUAD LEAD - Product Status 54
  • Table 68: X4 SYSTEM + QUAD LEAD - Product Description 54
  • Table 69: Boston Scientific Corp - Ongoing Clinical Trials Overview 55
  • Table 70: Next Generation Quad Polar CRT-D - Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan 56
  • Table 71: S-ICD System 2.0 - A Prospective Randomised Comparative Trial of Subcutaneous Implantable Cardioverter-defibrillator Implantation with and without Defibrillation Testing 57
  • Table 72: S-ICD System 1.5 - A Prospective Randomised Comparative Trial of Subcutaneous Implantable Cardioverter-defibrillator Implantation with and without Defibrillation Testing 58
  • Table 73: EMBLEM MRI S-ICD System - Aged Patients - Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD) 59
  • Table 74: Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 75: Raul Pacemaker - Product Status 60
  • Table 76: Raul Pacemaker - Product Description 60
  • Table 77: CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 78: CardiaLen Device - Atrial Fibrillation - Product Status 61
  • Table 79: CardiaLen Device - Atrial Fibrillation - Product Description 61
  • Table 80: CardiaLen, Inc. - Ongoing Clinical Trials Overview 62
  • Table 81: CardiaLen Device - Atrial Fibrillation - An International Clinical Feasibility Study to Evaluate the Safety and Performance of Low-Energy Unpinning Termination Therapy in Patients with VT/VF 63
  • Table 82: CardiaLen Device - Atrial Fibrillation - Unpinning Pulse Termination Therapy for Ventricular Tachyarrhythmias 63

List of Figures

  • Figure 1: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development 19
  • Figure 2: Cardiac Rhythm Management Devices - Pipeline Products by Segment 20
  • Figure 3: Cardiac Rhythm Management Devices - Pipeline Products by Territory 21
  • Figure 4: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path 22
  • Figure 5: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date 23
  • Figure 6: Cardiac Rhythm Management Devices - Ongoing Clinical Trials 24